Literature DB >> 36199750

Effect of APOE alleles on the glial transcriptome in normal aging and Alzheimer's disease.

Alberto Serrano-Pozo1,2,3, Zhaozhi Li1,2, Ayush Noori1,2, Huong N Nguyen1, Aziz Mezlini1,2,3, Liang Li1, Eloise Hudry1,3, Rosemary J Jackson1,3, Bradley T Hyman1,2,3, Sudeshna Das1,2,3.   

Abstract

The roles of APOEε4 and APOEε2-the strongest genetic risk and protective factors for Alzheimer's disease-in glial responses remain elusive. We tested the hypothesis that APOE alleles differentially impact glial responses by investigating their effects on the glial transcriptome from elderly control brains with no neuritic amyloid plaques. We identified a cluster of microglial genes that are upregulated in APOEε4 and downregulated in APOEε2 carriers relative to APOEε3 homozygotes. This microglia-APOE cluster is enriched in phagocytosis-including TREM2 and TYROBP-and proinflammatory genes, and is also detectable in brains with frequent neuritic plaques. Next, we tested these findings in APOE knock-in mice exposed to acute (lipopolysaccharide challenge) and chronic (cerebral β-amyloidosis) insults and found that these mice partially recapitulate human APOE-linked expression patterns. Thus, the APOEε4 allele might prime microglia towards a phagocytic and proinflammatory state through an APOE-TREM2-TYROBP axis in normal aging as well as in Alzheimer's disease.

Entities:  

Year:  2021        PMID: 36199750      PMCID: PMC9531903          DOI: 10.1038/s43587-021-00123-6

Source DB:  PubMed          Journal:  Nat Aging        ISSN: 2662-8465


  79 in total

1.  The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease.

Authors:  S S Mirra; A Heyman; D McKeel; S M Sumi; B J Crain; L M Brownlee; F S Vogel; J P Hughes; G van Belle; L Berg
Journal:  Neurology       Date:  1991-04       Impact factor: 9.910

2.  A Unique Microglia Type Associated with Restricting Development of Alzheimer's Disease.

Authors:  Hadas Keren-Shaul; Amit Spinrad; Assaf Weiner; Orit Matcovitch-Natan; Raz Dvir-Szternfeld; Tyler K Ulland; Eyal David; Kuti Baruch; David Lara-Astaiso; Beata Toth; Shalev Itzkovitz; Marco Colonna; Michal Schwartz; Ido Amit
Journal:  Cell       Date:  2017-06-08       Impact factor: 41.582

3.  Complement C3 deficiency protects against neurodegeneration in aged plaque-rich APP/PS1 mice.

Authors:  Qiaoqiao Shi; Saba Chowdhury; Rong Ma; Kevin X Le; Soyon Hong; Barbara J Caldarone; Beth Stevens; Cynthia A Lemere
Journal:  Sci Transl Med       Date:  2017-05-31       Impact factor: 17.956

4.  Frequency of the apolipoprotein E epsilon 2 allele is diminished in sporadic Alzheimer disease.

Authors:  H L West; G W Rebeck; B T Hyman
Journal:  Neurosci Lett       Date:  1994-07-04       Impact factor: 3.046

Review 5.  Neuropathological stageing of Alzheimer-related changes.

Authors:  H Braak; E Braak
Journal:  Acta Neuropathol       Date:  1991       Impact factor: 17.088

6.  Apolipoprotein E, especially apolipoprotein E4, increases the oligomerization of amyloid β peptide.

Authors:  Tadafumi Hashimoto; Alberto Serrano-Pozo; Yukiko Hori; Kenneth W Adams; Shuko Takeda; Adrian Olaf Banerji; Akinori Mitani; Daniel Joyner; Diana H Thyssen; Brian J Bacskai; Matthew P Frosch; Tara L Spires-Jones; Mary Beth Finn; David M Holtzman; Bradley T Hyman
Journal:  J Neurosci       Date:  2012-10-24       Impact factor: 6.167

7.  APOE4 Causes Widespread Molecular and Cellular Alterations Associated with Alzheimer's Disease Phenotypes in Human iPSC-Derived Brain Cell Types.

Authors:  Yuan-Ta Lin; Jinsoo Seo; Fan Gao; Heather M Feldman; Hsin-Lan Wen; Jay Penney; Hugh P Cam; Elizabeta Gjoneska; Waseem K Raja; Jemmie Cheng; Richard Rueda; Oleg Kritskiy; Fatema Abdurrob; Zhuyu Peng; Blerta Milo; Chung Jong Yu; Sara Elmsaouri; Dilip Dey; Tak Ko; Bruce A Yankner; Li-Huei Tsai
Journal:  Neuron       Date:  2018-05-31       Impact factor: 17.173

8.  TREM2 deficiency exacerbates tau pathology through dysregulated kinase signaling in a mouse model of tauopathy.

Authors:  Shane M Bemiller; Tyler J McCray; Kevin Allan; Shane V Formica; Guixiang Xu; Gina Wilson; Olga N Kokiko-Cochran; Samuel D Crish; Cristian A Lasagna-Reeves; Richard M Ransohoff; Gary E Landreth; Bruce T Lamb
Journal:  Mol Neurodegener       Date:  2017-10-16       Impact factor: 14.195

9.  Reactive or transgenic increase in microglial TYROBP reveals a TREM2-independent TYROBP-APOE link in wild-type and Alzheimer's-related mice.

Authors:  Mickael Audrain; Jean-Vianney Haure-Mirande; Justyna Mleczko; Minghui Wang; Jennifer K Griffin; Peter H St George-Hyslop; Paul Fraser; Bin Zhang; Sam Gandy; Michelle E Ehrlich
Journal:  Alzheimers Dement       Date:  2020-12-12       Impact factor: 21.566

10.  APOE2 orchestrated differences in transcriptomic and lipidomic profiles of postmortem AD brain.

Authors:  Iliya Lefterov; Cody M Wolfe; Nicholas F Fitz; Kyong Nyon Nam; Florent Letronne; Richard J Biedrzycki; Julia Kofler; Xianlin Han; Jianing Wang; Jonathan Schug; Radosveta Koldamova
Journal:  Alzheimers Res Ther       Date:  2019-12-30       Impact factor: 6.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.